Rapid PCR Revenue and Competitors

Bern,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Rapid PCR's estimated annual revenue is currently $6.7M per year.(i)
  • Rapid PCR's estimated revenue per employee is $155,000

Employee Data

  • Rapid PCR has 43 Employees.(i)
  • Rapid PCR grew their employee count by -27% last year.

Rapid PCR's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Rapid PCR?

ender provides rapid and reliable testing kits for acute COVID–19, capable of processing multiple samples at once and delivering results within just 30 minutes. These tests can be used in hospitals as well as right on-site. ender is here for you in your efforts against COVID-19.

keywords:N/A

N/A

Total Funding

43

Number of Employees

$6.7M

Revenue (est)

-27%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Rapid PCR News

2022-04-20 - Delhi Capital's Mitchell Marsh tested COVID+ in an antigen test but negative in RT PCR testing; Know all about the difference between the two and why it may have happened

The Delhi Capital player had tested negative in his first mandatory RT-PCR test, which was conducted after he tested COVID positive in a Rapid...

2022-04-19 - UF Health researchers help develop highly accurate, 30-second coronavirus test

The motherboard of a COVID-19 rapid testing device that UF Health ... as the gold standard of testing, a PCR test, in 30 seconds.

2022-03-30 - PCR vs. rapid test: Differences and more

People use polymerase chain reaction (PCR) and rapid (antigen) tests to diagnose COVID-19. The tests can differ in their timing, accuracy,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5M438%N/A
#2
$5.6M48N/AN/A
#3
$7.9M4936%N/A
#4
N/A4932%N/A
#5
N/A52100%N/A